Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025. Read more about NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.
Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Read more about Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study. Read more about YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study.
CRE25-035: Vascular Endothelial Growth Factor Inhibitor-Induced Radiation Recall Tracheitis in a CASTLE Carcinoma of the Thyroid Patient. Read more about CRE25-035: Vascular Endothelial Growth Factor Inhibitor-Induced Radiation Recall Tracheitis in a CASTLE Carcinoma of the Thyroid Patient.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025. Read more about NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.
Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities- A Rigorous Structural Equation Modeling. Read more about Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities- A Rigorous Structural Equation Modeling.
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025. Read more about NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025. Read more about NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025.
NCCN Guidelines® Insights: Survivorship, Version 2.2024. Read more about NCCN Guidelines® Insights: Survivorship, Version 2.2024.
